A news post shares that the company will allow limited early access to retatrutide for some patients ahead of approval. Forum users react by mentioning their own trial signups, requesting the article link, noting they no longer qualify due to health improvements, and referencing existing unofficial options.
What this discussion establishesNothing here is advice.
A Reuters report from early August states the company will let a small number of patients access their experimental obesity medication ahead of any FDA approval.
Man, I went and enrolled myself in some medical research study testing a calcitonin receptor stimulator. Still my oldest buddy hangs around though.
I appreciate you bringing that up. It's helpful to hear about.
Sounds interesting, any chance you could share where to find the piece?
Having fixed up all my ailments and shed the excess pounds, I'm no longer eligible for this. Yet I really crave inclusion and a sample of the untainted product.
Try this for the article.
I've noticed this kind of thing ended up happening without any plan over the last few years already 😊
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.